Compton Capital Management Inc Abbott Laboratories Transaction History

Compton Capital Management Inc

$4.32 Billion
Q2 2023

A detailed history of Compton Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Compton Capital Management Inc holds 2,056 shares of ABT stock, worth $268,287. This represents 5.19% of its overall portfolio holdings.

Number of Shares

2,056

Previous 8,591 76.07%

Holding current value

$268,287

Previous $869,000 25693.44%

% of portfolio

5.19%

Previous 1.87%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$100.78 - $112.29 $658,597 - $733,815	-6,535 Reduced 76.07%	2,056 $224 Million
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $1.51 Million - $1.77 Million	-15,550 Reduced 64.41%	8,591 $869,000
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $250,197 - $293,520	-2,632 Reduced 9.83%	24,141 $2.65 Million
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $71,021 - $82,230	-734 Reduced 2.67%	26,773 $2.59 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $579,961 - $700,988	-5,682 Reduced 17.12%	27,507 $2.99 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $18,243 - $22,246	-160 Reduced 0.48%	33,189 $3.93 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $21,815 - $24,134	-187 Reduced 0.56%	33,349 $3.94 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $26,447 - $31,132	250 Added 0.75%	33,536 $3.89 Million
Q1 2021 May 04, 2021	SELL	$108.84 - $128.23 $31,563 - $37,186	-290 Reduced 0.86%	33,286 $3.99 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $73,312 - $89,032	-800 Reduced 2.33%	33,576 $3.65 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $1,531 - $1,960	-20 Reduced 0.06%	34,376 $3.14 Million
Q1 2020 May 06, 2020	SELL	$62.82 - $91.86 $19,097 - $27,925	-304 Reduced 0.88%	34,396 $2.71 Million
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $7,851 - $8,740	-100 Reduced 0.29%	34,700 $3.01 Million
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $45,012 - $48,807	-550 Reduced 1.56%	34,800 $2.91 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $7,288 - $8,500	-100 Reduced 0.28%	35,350 $2.97 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $21,521 - $26,019	-325 Reduced 0.91%	35,450 $2.83 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $41,696 - $47,235	-636 Reduced 1.75%	35,775 $2.59 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $1,496 - $1,652	-26 Reduced 0.07%	36,411 $2.22 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $5,627 - $6,362	-100 Reduced 0.27%	36,437 $2.18 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $16,104 - $17,241	-300 Reduced 0.81%	36,537 $2.09 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $35,131 - $39,210	-731 Reduced 1.95%	36,837 $1.97 Million
Q2 2017 Aug 14, 2017	BUY	N/A	37,568	37,568 $1.83 Million

Others Institutions Holding ABT

# of Institutions

3,290

Shares Held

1.34B

Call Options Held

9.72M

Put Options Held

8.45M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Compton Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Compton Capital Management Inc with notifications on news.

Account

Compton Capital Management Inc Abbott Laboratories Transaction History